Crossmark

Evaluation of target dose inhomogeneity in breast cancer treatment due to tissue elemental differences

Crossref DOI link: https://doi.org/10.1186/s13014-018-1022-1

Published Online: 2018-05-15

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fogliata, A. http://orcid.org/0000-0002-2282-9894
De Rose, F.

Stravato, A.

Reggiori, G.

Tomatis, S.

Scorsetti, M.

Cozzi, L.
License Information

Text and Data Mining valid from 2018-05-15
More Information

Article History

Received: 13 February 2018

Accepted: 11 April 2018

First Online: 15 May 2018

Ethics approval and consent to participate

: All patients signed, at hospital admission, a consent for the use of their data for retrospective and scientific investigations.

: L. Cozzi acts as Scientific Advisor to Varian Medical Systems and is Clinical Research Scientist at Humanitas Cancer Center. All other co-authors have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.